Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease

Abroad (travel likely)Recruiting

Conditions

COPD

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chu Bordeaux, Bordeaux, France
Contact: Study coordinator (MAEVA ZYSMAN) · maeva.zysman@chu-bordeaux.fr
Chu Lille, Lille, France
Contact: Study coordinator (OLIVIER LE ROUZIC) · Olivier.LEROUZIC@chu-lille.fr
Chu Lille, Lille, France
Contact: Study coordinator (THIERRY PEREZ) · Thierry.PEREZ@chu-lille.fr
Chu Nancy-Brabois, Nancy, France
Contact: Study coordinator (BRUNO RIBEIRO-BAPTISTA) · B.RIBEIROBAPTISTA@chru-nancy.fr
Hopital Cochin, Paris, France
Contact: Study coordinator (PIERRE-REGIS BURGEL) · pierre-regis.burgel@aphp.fr
Chu Reims, Reims, France
Contact: Study coordinator (GAETAN DESLEE) · gdeslee@chu-reims.fr
Chu Saint Etienne, Saint-Etienne, France
Contact: Study coordinator (ISABELLE COURT-FORTUNE) · isabelle.court_fortune@chu-st-etienne.fr

Study leads

Nicolas ROCHE
Principal Investigator
HOPITAL COCHIN

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD

COPD

Abroad (travel likely)RecruitingPHASE1

Chengdu, China

Continuous Versus High Intensity Interval Exercise in Chronic Obstructive Pulmonary Disease

COPD

Abroad (travel likely)Recruiting

Thessaloniki, Greece

MoblO2 to Maintain Oxygenation

COPD (Chronic Obstructive Pulmonary Disease) · Intersitital Lung Disease

Abroad (travel likely)Recruiting

Denver, United States

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Chronic Obstructive Pulmonary Disease (COPD)

Abroad (travel likely)RecruitingPHASE3

Foley, United States · Mobile, United States